<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta name="viewport" content="width=device-width, initial-scale=1.0"/>
<title>How to Choose a Compounded GLP-1 Pharmacy: What Patients Need to Know (2026) | Ondra Health</title>
<meta name="description" content="Most GLP-1 telehealth platforms don't tell you which pharmacy fills your prescription — or why it matters. Here's what to look for, what to ask, and what the 2025–2026 FDA changes mean for your treatment."/>
<script type="application/ld+json">
{ "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [
{ "@type": "Question", "name": "How do I know if a compounded GLP-1 pharmacy is legitimate?", "acceptedAnswer": { "@type": "Answer", "text": "A legitimate compounded GLP-1 pharmacy should be a state-licensed 503A compounding pharmacy, verifiable through the relevant state board of pharmacy. It should follow USP <797> sterile compounding standards, be licensed to ship to your specific state, and be named publicly by the telehealth platform prescribing your medication. Red flags include vague references to 'our pharmacy network' without naming the specific pharmacy, claims of 503B-sourced compounded GLP-1s in 2026 (no longer a legal pathway), and instant approvals with minimal clinical intake." } },
{ "@type": "Question", "name": "What is the difference between a 503A and 503B compounding pharmacy for GLP-1?", "acceptedAnswer": { "@type": "Answer", "text": "503A pharmacies are state-licensed and dispense only on patient-specific prescriptions. They are regulated by their state board of pharmacy and are the legal pathway for compounded semaglutide and tirzepatide in 2026. 503B outsourcing facilities are federally registered and were designed for hospital bulk supply — they are no longer a legal source for compounded GLP-1s after the FDA resolved the semaglutide and tirzepatide shortages in 2025." } },
{ "@type": "Question", "name": "Why can't I get compounded tirzepatide from a 503B pharmacy in 2026?", "acceptedAnswer": { "@type": "Answer", "text": "The FDA <a href="https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize" target="_blank" rel="noopener noreferrer">declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025</a>. These resolutions ended the legal basis for 503B outsourcing facilities to compound these drugs at scale. Courts upheld the FDA's authority in 2025. In April 2026, the FDA proposed formally excluding semaglutide and tirzepatide from the 503B bulks list entirely. Compounded GLP-1s in 2026 are legal only through 503A pharmacies under patient-specific prescriptions with documented clinical need." } },
{ "@type": "Question", "name": "Does the pharmacy matter for compounded GLP-1 quality?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. The pharmacy determines the sterility standards of your medication, which states you can be served in, what additives are included in your formulation, and whether the compounding is operating within current FDA guidelines. A transparent telehealth provider will name their pharmacy partner publicly so patients can verify the pharmacy's license and accreditation before starting treatment." } },
{ "@type": "Question", "name": "Which states restrict compounded semaglutide or tirzepatide?", "acceptedAnswer": { "@type": "Answer", "text": "State availability varies by pharmacy. For example, Hallandale Pharmacy (503A) does not ship to CA, KS, AR, MI, MN, AL, HI, MS, or MA. Boudreaux's New Drug Store (503A) is restricted in AR, CT, HI, and NJ. Other 503A pharmacies such as Vials RX and Strive Pharmacy are available in all 50 states. Always confirm your specific state's availability with your telehealth provider before starting treatment." } },
{ "@type": "Question", "name": "What additives are in compounded semaglutide and tirzepatide?", "acceptedAnswer": { "@type": "Answer", "text": "Common additives in compounded GLP-1 formulations include Vitamin B12 (for energy support), Glycine (an amino acid stabilizer), B12/Glycine blends, and Vitamin B6. Some pharmacies offer pure formulations with no additives. Neither approach is clinically superior — additive preferences and individual needs are determined by your prescribing provider. Additives are not present in FDA-approved brand-name versions." } }
] }
</script>
</head>
<body>
<section class="ondra-article-page"> <div class="ondra-article-hero"> <div class="ondra-article-container"> <div class="ondra-article-meta-row"> <span class="ondra-meta-pill">⏱ 9 min read</span> <span class="ondra-meta-pill">🏷 Medication Guides</span> </div> <h1 class="ondra-article-title">How to Choose a Compounded GLP-1 Pharmacy: What Patients Need to Know (2026)</h1> <p class="ondra-article-intro">Most telehealth platforms that prescribe compounded semaglutide or tirzepatide don't tell you which pharmacy fills your prescription — or why it matters. The pharmacy behind your prescription determines your medication's sterility standards, which states can be served, what additives are in your formulation, and whether your compounding is still operating within current FDA guidelines. Here's what to look for, what to ask, and what the 2025–2026 regulatory changes mean for patients.</p> </div> </div> <div class="ondra-article-container ondra-article-body"> <div class="ondra-article-layout" id="ondraArticleLayout"> <div class="ondra-article-main" id="ondraArticleMain"> <a href="/blog" class="ondra-back-link">← Back to all articles</a> <div class="ondra-takeaways-card"> <h2 class="ondra-card-heading">Key takeaways</h2> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Compounded GLP-1s in 2026 are legal only through <strong>503A state-licensed pharmacies</strong> — the 503B large-scale compounding pathway closed when FDA shortages were resolved in 2025.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>A legitimate provider should <strong>name their pharmacy partner publicly</strong> — not just reference "our pharmacy network."</p></div> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>State availability varies by pharmacy. Some 503A pharmacies <strong>cannot ship to CA, MA, MI, and others</strong> — confirm before you start.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Formulation additives like <strong>B12, Glycine, and B6</strong> vary by pharmacy. Neither additive nor no-additive formulations are clinically superior — it depends on your individual case.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>In April 2026, the FDA proposed <strong>formally excluding semaglutide and tirzepatide from the 503B bulks list</strong> — pending final rule after June 2026 public comment period.</p></div> </div> <div class="ondra-section"> <h2>Why the pharmacy question became more complicated in 2025–2026</h2> <p>From roughly 2022 through early 2025, compounded GLP-1 medications existed in a relatively open regulatory window. The FDA had placed both semaglutide and tirzepatide on its drug shortage list due to manufacturing backlogs from Novo Nordisk and Eli Lilly. That shortage designation allowed both 503A and 503B compounding pharmacies to legally produce and dispense these medications at scale.</p> <p>That window has now closed — and the regulatory picture has tightened considerably.</p> <div class="ondra-info-card"> <p class="ondra-info-title">The 2025 enforcement timeline</p> <p>The FDA <a href="https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize" target="_blank" rel="noopener noreferrer">declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025</a>. Both announcements came with enforcement deadlines that ended large-scale compounding:</p> <ul> <li><strong>503B outsourcing facilities</strong> (large-scale compounders) were required to stop compounding both drugs. Federal courts upheld the FDA's authority in the <em>Outsourcing Facilities Association v. FDA</em> cases in 2025.</li> <li><strong>503A pharmacies</strong> (state-licensed, patient-specific) can still compound these medications legally — but only on valid individual prescriptions with documented clinical need, using formulations that are not "essentially a copy" of the branded drug.</li> </ul> <p>Then in April 2026, the <a href="https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list" target="_blank" rel="noopener noreferrer">FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list</a> entirely — potentially closing any remaining pathway for large-scale compounding permanently, pending public comment through June 2026.</p> </div> <p><strong>What this means for patients:</strong> If you're getting compounded semaglutide or tirzepatide today, it should be coming from a named, licensed 503A pharmacy on a valid patient-specific prescription. Any platform claiming 503B-sourced compounded GLP-1s as a routine offering is either outdated or operating in a legally uncertain space.</p> </div> <div class="ondra-section"> <h2>503A vs. 503B: the distinction that still matters in 2026</h2> <p>Even with the regulatory changes, understanding the difference between these two pharmacy types helps you evaluate whether your source is legitimate. We cover this in more depth in our guide to <a href="/blog/503a-vs-503b-compounding-pharmacy">503A vs. 503B compounding pharmacies</a>.</p> <div class="ondra-info-card"> <p class="ondra-info-title">503A pharmacies (the legal 2026 pathway)</p> <p>State-licensed compounding pharmacies that dispense only on valid patient-specific prescriptions. They are regulated by their state board of pharmacy, cannot bulk-stockpile in advance of prescriptions, and must follow USP <797> sterile compounding standards. This is the correct and legal pathway for compounded GLP-1s in 2026.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">503B outsourcing facilities (no longer a legal GLP-1 source)</p> <p>Federally registered facilities designed for hospital and clinical bulk supply. They were a major source of compounded semaglutide and tirzepatide during the shortage period. Since the shortages were resolved in 2025 and courts upheld FDA enforcement, 503B compounding of these drugs is no longer legally permissible.</p> </div> <p>The practical takeaway: ask your telehealth platform which specific 503A pharmacy is filling your prescription. A legitimate provider should be able to name it — and you should be able to verify that pharmacy's license through the relevant state board.</p> </div> <div class="ondra-section"> <h2>5 questions to ask before you start</h2> <div class="ondra-info-card"> <p class="ondra-info-title">1. Which pharmacy fills my prescription — and what is their license status?</p> <p>A trustworthy platform names their pharmacy partner. You should be able to look up that pharmacy's license with the relevant state board of pharmacy. If the provider says "one of our network pharmacies" without specifics, that's a red flag — not just for transparency but potentially for regulatory compliance.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">2. Does the pharmacy follow USP <797> sterile compounding standards?</p> <p>GLP-1 injectables require sterile compounding under specific controlled conditions. USP <797> is the professional standard for this. Some pharmacies also carry <a href="https://www.pcab.org/" target="_blank" rel="noopener noreferrer">PCAB (Pharmacy Compounding Accreditation Board) accreditation</a> — third-party verification of quality standards that goes beyond the minimum state requirements. A reputable pharmacy will confirm both.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">3. Is the pharmacy licensed in my state?</p> <p>503A pharmacies are state-licensed, which means they can only ship to states where they hold a valid license. Some pharmacies serve all 50 states; others have restrictions — particularly in states like California, Massachusetts, Michigan, and Minnesota, which have additional regulations on compounded medications. This is one of the most common sources of patient frustration: getting approved, paying, and then finding out your pharmacy can't ship to your state. A transparent provider shows you state-by-state availability before you start your intake — like our <a href="/service-areas">state availability finder</a>, which shows exactly which pharmacies serve your state before you begin.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">4. What's actually in my formulation?</p> <p>Compounded medications can include supportive additives beyond the active ingredient. Common additives in GLP-1 formulations include:</p> <ul> <li><strong>Vitamin B12</strong> — often included to help with energy levels during the early weeks of treatment</li> <li><strong>Glycine</strong> — an amino acid that helps stabilize the peptide and may support sleep quality and collagen synthesis</li> <li><strong>B12/Glycine blend</strong> — combined formulations offered by some pharmacies</li> <li><strong>Vitamin B6</strong> — included by some pharmacies as a metabolic co-factor</li> </ul> <p>None of these additives are in the branded drugs. None are FDA-reviewed in this context. If you have allergies, sensitivities, or simply prefer a clean formulation, ask what's in your specific compound before starting.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">5. Is there documented clinical rationale for my prescription?</p> <p>Post-shortage enforcement means a licensed prescriber must document individualized clinical justification for a compounded prescription — patient preference or cost savings alone no longer qualifies. Legitimate platforms collect a real clinical intake: medical history, current medications, BMI, comorbidities, and a licensed provider review. If a platform approves you in 60 seconds with minimal information, the prescription quality may not hold up to regulatory scrutiny.</p> </div> </div> <div class="ondra-section"> <h2>What pharmacy transparency actually looks like</h2> <div class="ondra-compare-table" role="table" aria-label="Pharmacy transparency comparison"> <div class="ondra-compare-row ondra-compare-header" role="row"> <div role="columnheader">What you should see</div> <div role="columnheader">Red flags</div> </div> <div class="ondra-compare-row" role="row"> <div role="cell">Named pharmacy partner(s) publicly listed</div> <div role="cell">"Our licensed pharmacy network" — no name given</div> </div> <div class="ondra-compare-row" role="row"> <div role="cell">State-by-state availability disclosed before intake</div> <div role="cell">No mention of state restrictions until after payment</div> </div> <div class="ondra-compare-row" role="row"> <div role="cell">503A designation clearly stated</div> <div role="cell">503B claimed as routine supply source in 2026</div> </div> <div class="ondra-compare-row" role="row"> <div role="cell">Additive ingredients listed per pharmacy</div> <div role="cell">"Proprietary blend" with no specifics</div> </div> <div class="ondra-compare-row" role="row"> <div role="cell">Pharmacy license verifiable via state board</div> <div role="cell">No license information provided or linkable</div> </div> <div class="ondra-compare-row" role="row"> <div role="cell">Provider review documented in patient record</div> <div role="cell">Instant approvals with minimal or no clinical intake</div> </div> </div> </div> <div class="ondra-section"> <h2>Does it matter which 503A pharmacy you use?</h2> <p>Within the universe of legitimate 503A pharmacies that are properly licensed, follow USP <797>, and operate transparently, the practical differences are smaller than the regulatory ones. The active ingredient is the same. The sterile compounding process is standardized.</p> <p>Where meaningful differences can exist:</p> <div class="ondra-info-card"> <p class="ondra-info-title">State availability</p> <p>Some 503A pharmacies are licensed in all 50 states; others have restrictions in 9–12 states. If you're in California, Massachusetts, Michigan, Minnesota, or several other states, your pharmacy options are narrower — and some platforms don't disclose this until you're already in the checkout flow.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">Formulation options</p> <p>If you want B12 or Glycine included — or specifically want a pure formulation with no additives — different pharmacies offer different options. Neither approach is clinically superior; it's about your preference and your provider's recommendation based on your individual case.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">Billing structure</p> <p>Some pharmacies are available on quarterly plans; others are monthly only. This can affect your total cost depending on the platform's pricing structure.</p> </div> </div> <div class="ondra-section"> <h2>Pharmacy partners at Ondra Health</h2> <p>Ondra works with six state-licensed 503A compounding pharmacies. Because pharmacy availability varies by state and formulation, we built a <a href="/service-areas">state-by-state availability tool</a> so patients can see exactly which pharmacies serve their state before they start their intake — no surprises at checkout.</p> <p>Our current pharmacy partners:</p> <div class="ondra-compare-table" role="table" aria-label="Ondra pharmacy partners"> <div class="ondra-compare-row ondra-compare-header" role="row"> <div role="columnheader">Pharmacy</div> <div role="columnheader">Type</div> <div role="columnheader">Medications</div> <div role="columnheader">Additives</div> <div role="columnheader">Availability</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Hallandale Pharmacy</div> <div role="cell" data-label="Type">503A</div> <div role="cell" data-label="Medications">Sema + Tirz</div> <div role="cell" data-label="Additives">None</div> <div role="cell" data-label="Availability">41 states (not CA, KS, AR, MI, MN, AL, HI, MS, MA)</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Boudreaux's New Drug Store</div> <div role="cell" data-label="Type">503A</div> <div role="cell" data-label="Medications">Sema + Tirz</div> <div role="cell" data-label="Additives">Glycine</div> <div role="cell" data-label="Availability">46 states (not AR, CT, HI, NJ)</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Vials RX</div> <div role="cell" data-label="Type">503A</div> <div role="cell" data-label="Medications">Sema + Tirz</div> <div role="cell" data-label="Additives">B12 + Glycine</div> <div role="cell" data-label="Availability">All 50 states</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Strive Pharmacy</div> <div role="cell" data-label="Type">503A</div> <div role="cell" data-label="Medications">Sema + Tirz</div> <div role="cell" data-label="Additives">B12/Glycine Blend</div> <div role="cell" data-label="Availability">All 50 states (monthly only)</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Quaker / Apothecary</div> <div role="cell" data-label="Type">503B</div> <div role="cell" data-label="Medications">Tirz only</div> <div role="cell" data-label="Additives">None</div> <div role="cell" data-label="Availability">All 50 states</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">The Pharmacy Hub / BPI Labs</div> <div role="cell" data-label="Type">503A + 503B</div> <div role="cell" data-label="Medications">Tirz only</div> <div role="cell" data-label="Additives">B6</div> <div role="cell" data-label="Availability">All 50 states</div> </div> </div> <p class="ondra-table-note">Pharmacy availability and formulations are subject to change. Use the <a href="/service-areas">state availability finder</a> or visit our <a href="/pharmacy-partners">pharmacy partners page</a> for current information by state.</p> </div> <div class="ondra-section"> <h2>Frequently asked questions</h2> <div class="ondra-faq-item"> <h3>How do I know if a compounded GLP-1 pharmacy is legitimate?</h3> <p>Look for a named, state-licensed 503A pharmacy whose license you can verify through the relevant state board. The pharmacy should follow USP <797> sterile compounding standards and be licensed to ship to your state. The telehealth platform should name them publicly — not just say "our pharmacy network." Instant approvals with minimal clinical intake are also a red flag for prescription quality.</p> </div> <div class="ondra-faq-item"> <h3>What is the difference between a 503A and 503B pharmacy for GLP-1s?</h3> <p>503A pharmacies are state-licensed and dispense only on patient-specific prescriptions — the legal pathway for compounded GLP-1s in 2026. 503B outsourcing facilities are federally registered and were designed for hospital bulk supply. They are no longer a legal source for compounded semaglutide or tirzepatide after the FDA resolved both drug shortages in 2025 and courts upheld enforcement.</p> </div> <div class="ondra-faq-item"> <h3>Why can't I get compounded tirzepatide from a 503B pharmacy in 2026?</h3> <p>The FDA declared the tirzepatide shortage resolved in December 2024 and semaglutide in February 2025, ending the legal basis for 503B bulk compounding of these drugs. Courts upheld FDA enforcement in the <a href="https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize" target="_blank" rel="noopener noreferrer"><em>Outsourcing Facilities Association v. FDA</em></a> cases in 2025. In April 2026, the FDA proposed formally excluding both drugs from the 503B bulks list. Compounded GLP-1s are only legal through 503A pharmacies under patient-specific prescriptions with documented clinical need.</p> </div> <div class="ondra-faq-item"> <h3>Does the pharmacy matter for compounded GLP-1 quality?</h3> <p>Yes. The pharmacy determines the sterility standards of your medication, which states you can be served in, what additives are in your formulation, and whether the compounding is operating within current FDA guidelines. Among properly licensed 503A pharmacies following USP <797>, quality differences are minimal — though they differ meaningfully from brand-name GLP-1s, which we cover in our <a href="/blog/compounded-vs-brand-name-glp-1">compounded vs. brand-name GLP-1 comparison</a> — but transparency about which pharmacy is involved is a meaningful indicator of a platform's overall legitimacy.</p> </div> <div class="ondra-faq-item"> <h3>Which states restrict compounded semaglutide or tirzepatide?</h3> <p>State availability varies by pharmacy. Hallandale Pharmacy cannot ship to CA, KS, AR, MI, MN, AL, HI, MS, or MA. Boudreaux's New Drug Store is restricted in AR, CT, HI, and NJ. Vials RX, Strive Pharmacy, Quaker/Apothecary, and BPI Labs are available in all 50 states. Always confirm your state's availability with your telehealth provider before completing your intake.</p> </div> <div class="ondra-faq-item"> <h3>What additives are in compounded semaglutide and tirzepatide?</h3> <p>Common additives include Vitamin B12 (energy support), Glycine (peptide stabilizer), B12/Glycine blends, and Vitamin B6. Some pharmacies offer pure formulations with no additives. None of these are in branded semaglutide or tirzepatide, and none are FDA-reviewed in this context. Neither additive nor no-additive formulations are clinically superior — ask your provider which is appropriate for you.</p> </div> </div> <p class="ondra-disclaimer">† This article is for informational purposes only and does not constitute medical advice. Regulatory information reflects publicly available FDA announcements and federal court decisions as of May 2026. The FDA's April 2026 proposal to exclude semaglutide and tirzepatide from the 503B bulks list is pending final determination after June 2026 public comment. Compounded medications available through Ondra Health are not FDA-approved. Always consult a qualified, licensed healthcare provider before starting, stopping, or changing any treatment.</p> </div> <aside class="ondra-article-sidebar" id="ondraSidebarCol"> <div class="ondra-sidebar-track" id="ondraSidebarTrack"> <div class="ondra-sidebar-card-wrap" id="ondraSidebarWrap"> <div class="ondra-sidebar-card" id="ondraSidebarCard"> <div class="ondra-sidebar-top"> <p class="ondra-sidebar-eyebrow">ONDRA HEALTH</p> <h3>GLP-1 treatment from $113/mo</h3> </div> <div class="ondra-sidebar-bottom"> <div class="ondra-sidebar-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Named, licensed pharmacy partners</p></div> <div class="ondra-sidebar-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>State availability shown before you start</p></div> <div class="ondra-sidebar-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Semaglutide & tirzepatide available</p></div> <div class="ondra-sidebar-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Free shipping, flat pricing every dose</p></div> <a href="https://intake.ondra.health/start-online-visit/glp1" class="ondra-sidebar-button" target="_blank" rel="noopener noreferrer">Start your intake <span aria-hidden="true">→</span></a> <p class="ondra-sidebar-note">Only charged if a provider approves your treatment.</p> </div> </div> </div> </div> </aside> </div> </div>
</section>
</body>
</html>